Work

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?

Year: 2008
Type: article
Source: Drug Safety
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2036508585
FWCI: 9.46
Cites: 113
Cited by: 317
Related to: 10